Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
Online dating has revolutionized dating by creating more opportunities to meet partners than ever before.
Read Full NewsLack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.
A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.
Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.
Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.
1.
Two-part prodrug system activates immune attack only in tumor's unique environment
2.
After all, Pulled Myeloma Drug May Help Treat the Illness.
3.
Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL
4.
A Chemo-Free Option for Some Advanced Endometrial Cancers?
5.
No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says
1.
A Comprehensive Guide To Understanding Plasma Osmolality
2.
Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy
3.
Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options
4.
Fresh Frozen Plasma: Its Role in Treating Trauma and Bleeding Disorders
5.
Exploring the Unknown: Unveiling the Mysteries of GIST Tumors
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
2.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge